# Sensex, Nifty set to open higher as bond markets steady 2026-08-18T02:26:40+00:00 | Business & Economy | Indian Opinion Desk Corroboration: 1 independent outlet (3 source reports) Indian shares are expected to open higher on Thursday, with GIFT Nifty futures at 24,241 points indicating a positive start for the benchmark Nifty 50, which closed at 24,078.3 on Wednesday. The uptick comes as global bond markets steadied after the US Treasury announced it would double buyback sizes for long-duration debt, sending the dollar lower and supporting Asian and US equities. However, The Hindu Business Line reports that elevated crude oil prices near $92 per barrel and persistent Middle East tensions were limiting risk appetite. The Nifty had fallen for seven consecutive sessions, losing 2.1% in its longest run of declines in 11 months. Foreign investors have sold a record $24.7 billion worth of Indian shares in 2026, though they were net buyers of Rs 4.1 billion on Wednesday. The market will watch the benchmark 6.94% 2036 bond yield after RBI policy minutes signalled the possibility of rate hikes ahead. ## Indian Opinion Analysis All three sources come from the same outlet, The Hindu Business Line, and present uniform, straight market reporting. No pro-government or critical framing is discernible. The coverage leads with the positive opening signal from GIFT Nifty and the US Treasury's bond-buyback move, then immediately caveats the upside with elevated crude oil and Middle East tensions. The seventh-session losing streak is acknowledged as a fact, not used to sensationalise. A careful reader should note that the article's primary narrative is 'positive but constrained', the rally rests on a technical policy fix abroad while domestic headwinds (oil, foreign selling) remain. Watch the actual Nifty opening versus the GIFT Nifty signal, and Brent crude's direction from $92, as the real test of this optimism. ## Coverage Coverage: 3 sources, 3 neutral - thehindubusinessline.com (neutral report) Leads with the positive opening signal but immediately caveats with oil and Middle East risks, no discernible government slant. - thehindubusinessline.com (2) (neutral report) - thehindubusinessline.com (3) (neutral report) Straight market-news format, no editorialising. Presents both the US Treasury catalyst and the domestic headwinds. This story was synthesised by AI from the 3 sources linked above. Updated: this story now draws on 3 sources. Last updated 2026-08-20T03:02:27+00:00. Tags: BSE Sensex, Concord Biotech, DII, FII, NSE Nifty, trading Canonical: https://indianopinion.org/concord-biotech-stock-surges-4-analysts-target-rs-1730/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/concord-biotech-stock-surges-4-analysts-target-rs-1730/#story-in-brief How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/